| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Dipartimento di Morfologia Umana Normale, Università di Trieste, 34138 Trieste, Italy [A. M. M., G. T., R. Bo., R. Ba., G. B., V. G., M. Z., P. N.], and Istituto di Anatomia Umana Normale, Cellular Signalling Laboratory, 40126 Bologna, Italy [L. M., L. C.]
Results from several laboratories have established the existence in the
nucleus of an autonomous polyphosphoinositide cycle, which is involved
in both cell proliferation and differentiation. A key step of
intranuclear polyphosphoinositide metabolism is the phospholipase
C-mediated generation of diacylglycerol (DAG). In insulin-like growth
factor (IGF)-I-stimulated Swiss 3T3 cells, a transient elevation of
intranuclear DAG levels is essential for attracting the
isoform of
protein kinase C (PKC) to the nucleus. Previous evidence has shown that
the nucleus also contains DAG kinase, i.e., the enzyme
that yields phosphatidic acid from DAG, thus terminating PKC-mediated
signaling events. Here we show that IGF-I treatment of quiescent Swiss
3T3 cells results in the stimulation of nuclear DAG kinase activity.
Time course analysis showed an inverse relationship between nuclear DAG
mass and DAG kinase activity levels. After IGF-I treatment, maximal
enhancement of DAG kinase activity was measured in the internal matrix
domain of the nucleus. PKC-
remained within the nuclear compartment,
even when nuclear DAG mass returned to basal levels. This was
conceivably due to interactions with specific nuclear PKC-binding
proteins, some of which were identified as lamins A, B, and C and
protein C23/nucleolin. Treatment of cells with two DAG kinase
inhibitors, R59022 and R59949, blocked the IGF-I-dependent rise in
nuclear DAG kinase activity and maintained elevated intranuclear levels
of DAG. The two inhibitors also markedly potentiated the mitogenic
effect of IGF-I. These results suggest that nuclear DAG kinase plays a
key role in regulating the levels of DAG present in the nucleus and
that DAG is a key molecule for the mitogenic effect that IGF-I exerts
on Swiss 3T3 cells.
This article has been cited by other articles:
![]() |
C. Evangelisti, P. L. Tazzari, M. Riccio, R. Fiume, Y. Hozumi, F. Fala, K. Goto, L. Manzoli, L. Cocco, and A. M. Martelli Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts FASEB J, October 1, 2007; 21(12): 3297 - 3307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer Mol. Cell. Proteomics, October 1, 2006; 5(10): 1745 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Los, F. P. Vinke, J. de Widt, M. K. Topham, W. J. van Blitterswijk, and N. Divecha The Retinoblastoma Family Proteins Bind to and Activate Diacylglycerol Kinase{zeta} J. Biol. Chem., January 13, 2006; 281(2): 858 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Zastrow, S. Vlcek, and K. L. Wilson Proteins that bind A-type lamins: integrating isolated clues J. Cell Sci., March 1, 2004; 117(7): 979 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Irvine Nuclear Lipid Signaling Sci. Signal., September 17, 2002; 2002(150): re13 - re13. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cogram, S. Tesh, J. Tesh, A. Wade, G. Allan, N. D.E. Greene, and A. J. Copp D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects Hum. Reprod., September 1, 2002; 17(9): 2451 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caricasole, E. Bettini, C. Sala, R. Roncarati, N. Kobayashi, F. Caldara, K. Goto, and G. C. Terstappen Molecular Cloning and Characterization of the Human Diacylglycerol Kinase beta (DGKbeta ) Gene. ALTERNATIVE SPLICING GENERATES DGKbeta ISOTYPES WITH DIFFERENT PROPERTIES J. Biol. Chem., February 8, 2002; 277(7): 4790 - 4796. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Faenza, A. Matteucci, L. Manzoli, A. M. Billi, M. Aluigi, D. Peruzzi, M. Vitale, S. Castorina, P.-G. Suh, and L. Cocco A Role for Nuclear Phospholipase Cbeta 1 in Cell Cycle Control J. Biol. Chem., September 22, 2000; 275(39): 30520 - 30524. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bregoli, J. J. Baldassare, and D. M. Raben Nuclear Diacylglycerol Kinase-theta Is Activated in Response to alpha -Thrombin J. Biol. Chem., June 22, 2001; 276(26): 23288 - 23295. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |